Interaction of ceftriaxone with penicillin-binding proteins of Escherichia coli in the presence of human serum albumin
Author(s) -
Roberta Fontana,
Marco Aldegheri,
Marco Ligozzi,
Giuliana Lo Cascio,
Giuseppe Cornaglia
Publication year - 1998
Publication title -
journal of antimicrobial chemotherapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.124
H-Index - 194
eISSN - 1460-2091
pISSN - 0305-7453
DOI - 10.1093/jac/42.1.95
Subject(s) - ceftriaxone , cefotaxime , penicillin binding proteins , cephalosporin , escherichia coli , penicillin , chemistry , albumin , serum albumin , in vivo , cephalosporin antibiotic , human serum albumin , blood proteins , antibiotics , microbiology and biotechnology , plasma protein binding , pharmacology , biochemistry , biology , gene
The binding of ceftriaxone, a cephalosporin that exhibits high serum protein binding and prolonged serum half-life, to penicillin-binding proteins (PBPs) of Escherichia coli K12 in the presence of human serum albumin was compared with plasma concentrations of cefotaxime, a cephalosporin with low serum protein binding and a short serum half-life. Ceftriaxone concentrations equivalent to those maintained in plasma for 8 h after an intravenous infusion of 1 g saturated PBPs 2 and 3. Cefotaxime saturated both PBPs at concentrations equivalent to those maintained for 2 h, and PBP 3 only at concentrations maintained for 2-8 h. These results indicate that high serum protein binding does not impair the ability of ceftriaxone to inhibit essential PBPs, and explain the high in-vivo efficacy of the drug.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom